Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening
Journal of Clinical Immunology · 2024
DOI: 10.1007/s10875-023-01640-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Immunology, 2024. Verfasst von Maarja Soomann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032, Zu…. Hauptthemen laut MEDLINE: Severe Combined Immunodeficiency, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation (SNSF), Georg und Bertha Schwyzer-Winiker-Stiftung, Wolfermann-Naegeli Foundation.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Newborn screening (NBS) for severe combined immunodeficiency (SCID) has been introduced in various countries with the aim of reducing morbidity and mortality. However, studies analyzing outcomes before and after the implementation of NBS programs remain limited. This study sought to compare the outcomes of SCID patients identified through Switzerland’s national SCID NBS program, introduced in January 2019, with those of a historical cohort diagnosed between 2007 and 2019. The study included seven patients (32%) identified through NBS, and 15 (68%) born before NBS implementation and diagnosed based on clinical signs. Children in the NBS group were younger at diagnosis (median age 9 days vs 9 months, P = .002) and at hematopoietic stem cell transplantation (HSCT, median age 5 months vs 11 months, P = .003) compared to the clinical group. The NBS group had a lower incidence of infections before HSCT (29% vs 93%, P = .004). Although not statistically significant, the overall survival rate on last follow-up was higher in the NBS group (86% vs 67%, P = .62). Importantly, patients with active infections undergoing HSCT had a significantly lower overall survival probability compared to those without ( P = .01). In conclusion, the introduction of NBS in Switzerland has led to earlier and often asymptomatic diagnosis of affected children, enabling timely intervention, infection prevention, and prompt treatment. These factors have contributed to higher survival rates in the NBS group. These findings underscore the critical importance of NBS for SCID, offering potential life-saving benefits through early detection and intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland. maarja.soomann@kispi.uzh.ch.
- Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland.
- Division of Stem Cell Transplantation and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Maarja Soomann
Förderung
- Swiss National Science Foundation (SNSF)
- Georg und Bertha Schwyzer-Winiker-Stiftung
- Wolfermann-Naegeli Foundation
- University of Zurich, ITINERARE
- University of Zurich
Zitieren
APA
Soomann, M., Prader, S., Pinto Monteiro, A., Zeilhofer, U., Hauri-Hohl, M., Güngör, T., Pachlopnik Schmid, J., Trück, J., & Felber, M. (2024). Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-023-01640-2
Vancouver
Soomann M, Prader S, Pinto Monteiro A, Zeilhofer U, Hauri-Hohl M, Güngör T, et al. Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening. Journal of Clinical Immunology. 2024. doi:10.1007/s10875-023-01640-2
BibTeX
@article{Soomann2024,
author = {Soomann, Maarja and Prader, Seraina and Pinto Monteiro, Aline and Zeilhofer, Ulrike and Hauri-Hohl, Mathias and Güngör, Tayfun and Pachlopnik Schmid, Jana and Trück, Johannes and Felber, Matthias},
title = {Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening},
journal = {Journal of Clinical Immunology},
year = {2024},
doi = {10.1007/s10875-023-01640-2}
}
EUVIMED